Record Free Cash Flow Powers AI Shift: Doximity Targets Paid Search TAM (DOCS Q4 2026 Earnings Call)

By Dr. Graph | Updated on May 31, 2026 | earnings

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Doximity recorded its first nine-digit quarterly cash flow to close the fiscal year, establishing a strong financial foundation to fund its aggressive expansion into clinical search artificial intelligence. This cash generation supports a strategic shift to monetize workflow tools directly.

Record Free Cash Flow Caps Strong Top-Line Execution

Doximity reported fourth-quarter revenue of $145 million, representing a 5% increase compared to the previous year. High operating efficiency enabled Doximity to generate a record $107 million in quarterly free cash flow, representing its first nine-digit cash flow period. This cash flow will fund ongoing strategic initiatives and software development.

Near-Term Margins Reflect Active Investments in Compute Capacity

For the upcoming fiscal year, Doximity expects annual revenue to reach $676 million at the upper end of its guidance range. Commenting on the strategic spending, Jeffrey Tangney explained, 'This is our AI investment year.' The company projects adjusted EBITDA to range from $323 million to $335 million to support this product transition.

Workflow Tools Reach Record Prescriber Engagement Levels

Physician engagement reached record levels as clinicians adopted Doximity as their daily clinical assistant. The company's benchmark workflow engagement reached over 800,000 unique quarterly active prescribers, representing an accelerated 30% growth year-over-year. In a side-by-side clinical search evaluation, surveyed physician residents selected Doximity's AI answers over its nearest competitor by a 2:1 ratio.

Commercial Search Strategy Unlocks Incremental Pharma Budgets

At its annual summit, Doximity introduced its commercial AI search monetization strategy to top pharmaceutical executives. The initiative aims to capture a share of the $19 billion overall paid search market by targeting high-intent professional search queries. Top-down mandates at several large pharmaceutical manufacturers require 10% to 20% of their ad budgets to be spent on innovative artificial intelligence products, driving strong early interest.

Frequently Asked Questions

Who was appointed as Doximity's new Chief Financial Officer?

Matt Sonefeldt was appointed as the new Chief Financial Officer starting in early June, succeeding Anna Bryson.

How many health systems have purchased Doximity's clinical AI suite?

A total of 140 health systems have purchased the clinical AI suite, which includes seven of the top twenty hospitals.

What is Doximity's target market for its new clinical AI monetization strategy?

Doximity is targeting the massive overall paid search market, which is estimated to be worth billions of dollars, to capture budgets from large pharmaceutical manufacturers.